Literature DB >> 33348529

In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics.

Jose V Carratalá1,2,3, Eric Brouillette4,5, Naroa Serna1,2,3, Alejandro Sánchez-Chardi6,7, Julieta M Sánchez1,2, Antonio Villaverde1,2,3, Anna Arís8, Elena Garcia-Fruitós8, Neus Ferrer-Miralles1,2,3, François Malouin4,5.   

Abstract

Oligomerization of antimicrobial peptides into nanosized supramolecular complexes produced in biological systems (inclusion bodies and self-assembling nanoparticles) seems an appealing alternative to conventional antibiotics. In this work, the antimicrobial peptide, GWH1, was N-terminally fused to two different scaffold proteins, namely, GFP and IFN-γ for its bacterial production in the form of such recombinant protein complexes. Protein self-assembling as regular soluble protein nanoparticles was achieved in the case of GWH1-GFP, while oligomerization into bacterial inclusion bodies was reached in both constructions. Among all these types of therapeutic proteins, protein nanoparticles of GWH1-GFP showed the highest bactericidal effect in an in vitro assay against Escherichia coli, whereas non-oligomerized GWH1-GFP and GWH1-IFN-γ only displayed a moderate bactericidal activity. These results indicate that the biological activity of GWH1 is specifically enhanced in the form of regular multi-display configurations. Those in vitro observations were fully validated against a bacterial infection using a mouse mastitis model, in which the GWH1-GFP soluble nanoparticles were able to effectively reduce bacterial loads.

Entities:  

Keywords:  Escherichia coli; Staphylococcus aureus; antimicrobial peptide; inclusion body; mouse mastitis model; protein nanoparticle; recombinant protein; therapeutic protein

Year:  2020        PMID: 33348529     DOI: 10.3390/pharmaceutics12121217

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  1 in total

1.  Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells.

Authors:  Irene Barguilla; Ugutz Unzueta; Jose Vicente Carratalá; Olivia Cano-Garrido; Antonio Villaverde; Alba Hernández; Neus Ferrer-Miralles
Journal:  Front Bioeng Biotechnol       Date:  2022-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.